Bharat Immunological & Biologicals Corporation Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19	Mar ' 18

Sources of funds

Owner's fund

Equity share capital

43.18

43.18

43.18

43.18

43.18

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

62.17

-9.14

-22.71

-12.50

-5.68

Loan funds

Secured loans

77.89

27.29

3.04

-

-

Unsecured loans

-

-

-

32.22

-

Total

183.24

61.33

23.51

62.90

37.50

Uses of funds

Fixed assets

Gross block

125.72

45.66

5.97

5.97

5.94

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

41.64

41.43

1.50

1.27

0.99

Net block

84.08

4.23

4.47

4.70

4.95

Capital work-in-progress

31.90

31.90

0.22

0.22

0.22

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

96.75

67.86

122.15

120.04

48.23

Less : current liabilities & provisions

29.49

42.65

103.32

62.06

15.91

Total net current assets

67.26

25.21

18.83

57.98

32.32

Miscellaneous expenses not written

-

-

-

-

-

Total

183.24

61.33

23.51

62.90

37.50

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.04

0.04

0.04

0.66

3.96

Number of equity sharesoutstanding (Lacs)

431.80

431.80

431.80

431.80

431.80